//
Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP Trial
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure